ABSTRACT
Construction of prognostic subgroups of patients with often performed to help understand the association of patient characteristics with survival times and to aid in the design of clinical trials. Applications include the development of stratification schemes for future clinical trials and the identification of patients who are suitable for a cancer therapy targeted at a specific prognostic group.
